An official website of the European Union How do you know?      
European Commission logo
JRC Publications Repository Menu

Mechanisms Leading to Gut Dysbiosis in COVID-19: Current Evidence and Uncertainties Based on Adverse Outcome Pathways

cover
Alteration of gut microbiota has been associated with COVID-19. However, the underlying mechanisms are still not well understood. Here, we proposed three potential interconnected pathways leading to gut dysbiosis as an adverse outcome following SARS-CoV-2 presence in the gastrointestinal tract. Evidence from literature and current uncertainties are reported for each step of each proposed pathway. One pathway investigates evidence that intestinal infection by SARS-CoV-2 leads to intestinal inflammation altering the gut microbiota. Another pathway links the binding of viral S protein to angiotensin converting enzyme 2 (ACE2) to dysregulation of this receptor activity, essential in intestinal homeostasis, notably for amino acid metabolism, leading to gut dysbiosis. Additionally, SARS-CoV-2 could induce gut dysbiosis by infecting intestinal bacteria. Assessing confidence in the proposed mechanisms on current evidence permits to identify inconsistencies and knowledge gaps orienting further research and proposing potential future management.
2022-09-22
MDPI
JRC129971
2077-0383 (online),   
https://www.mdpi.com/2077-0383/11/18/5400,    https://publications.jrc.ec.europa.eu/repository/handle/JRC129971,   
10.3390/jcm11185400 (online),   
Language Citation
NameCountryCityType
Datasets
IDTitlePublic URL
Dataset collections
IDAcronymTitlePublic URL
Scripts / source codes
DescriptionPublic URL
Additional supporting files
File nameDescriptionFile type 
Show metadata record  Copy citation url to clipboard  Download BibTeX
Items published in the JRC Publications Repository are protected by copyright, with all rights reserved, unless otherwise indicated. Additional information: https://ec.europa.eu/info/legal-notice_en#copyright-notice